Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Sandy W. Wong"'
Autor:
Sandy W. Wong, Noffar Bar, María Victoria Mateos, Paz Ribas, Markus Hansson, Laura Paris, Craig Hofmeister, Paula Rodriguez-Otero, Maria Aranzazu Bermúdez, Armando Santoro, Andrew J. Yee, Maria Creignou, Cristina Encinas, Claudio Cerchione, Javier de la Rubia, Albert Oriol, Barbara Ferstl, Britta Besemer, Jinjie Chen, Alexander Chung, Isaac W. Boss, Allison Gaudy, Shaoyi LI, Kevin Hsu, Colin Godwin, Michael R. Burgess, Jesús San-Miguel, Luciano Jose Costa
Publikováno v:
HemaSphere, Vol 7, p e1220745 (2023)
Externí odkaz:
https://doaj.org/article/2230834f84a148e3a0a1059145ec090f
Autor:
Isaac Boss, Ethan Thompson, Allison Gaudy, Thi Minh Diem Vu, Colin Godwin, Michael Burgess, Sandy W. Wong, Luciano Costa
Publikováno v:
HemaSphere, Vol 7, p e77796ce (2023)
Externí odkaz:
https://doaj.org/article/f2c17c763e2d4aaba325c9c200fa161e
Autor:
Ian D. Ferguson, Bonell Patiño-Escobar, Sami T. Tuomivaara, Yu-Hsiu T. Lin, Matthew A. Nix, Kevin K. Leung, Corynn Kasap, Emilio Ramos, Wilson Nieves Vasquez, Alexis Talbot, Martina Hale, Akul Naik, Audrey Kishishita, Priya Choudhry, Antonia Lopez-Girona, Weili Miao, Sandy W. Wong, Jeffrey L. Wolf, Thomas G. Martin, Nina Shah, Scott Vandenberg, Sonam Prakash, Lenka Besse, Christoph Driessen, Avery D. Posey, R. Dyche Mullins, Justin Eyquem, James A. Wells, Arun P. Wiita
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
The myeloma cell surface proteome regulates plasma cell biology and delineates therapy targets. Here, the authors profile the myeloma surfaceome at baseline and in drug resistance, finding the potential target CCR10, and include a streamlined approac
Externí odkaz:
https://doaj.org/article/c60c92825695486592fb827ec64cf75c
Autor:
Joaquin Martinez-Lopez, Rafael Alonso, Sandy W. Wong, Rafael Rios, Nina Shah, Yanira Ruiz-Heredia, Jose Maria Sanchez-Pina, Ricardo Sanchez, Natasha Bahri, Irene Zamanillo, Maria Poza, Natalia Buenache, Cristina Encinas, Luis Juarez, Fatima Miras, Luis Collado, Santiago Barrio, Thomas Martin, Maria Teresa Cedena, Jeffrey Wolf
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-4 (2021)
Abstract The assessment of measurable residual disease (MRD) in bone marrow has proven of prognostic relevance in patients with multiple myeloma (MM). Nevertheless, and unlike other hematologic malignancies, the use of MRD results to make clinical de
Externí odkaz:
https://doaj.org/article/a1b849d4a0814fbab61ca95434018518
Autor:
Rahul Banerjee, Ann A. Lazar, Lisa Dunn, Jennifer Knoche, Mimi Lo, Shagun Arora, Sandy W. Wong, Jeffrey L. Wolf, Thomas G. Martin III, Anand Dhruva, Nina Shah
Publikováno v:
eJHaem, Vol 2, Iss 2, Pp 276-279 (2021)
Abstract Multiple myeloma patients undergoing autologous stem cell transplantation (ASCT) may receive benzodiazepine or zolpidem‐class (B/Z) medications despite their risks in older patients. Of 205 myeloma patients (36% aged 65+) who underwent ASC
Externí odkaz:
https://doaj.org/article/e518401584a44be7a7aabbb0936cbf09
Autor:
Hector H. Huang, Ian D. Ferguson, Alexis M. Thornton, Prabhakar Bastola, Christine Lam, Yu-Hsiu T. Lin, Priya Choudhry, Margarette C. Mariano, Makeba D. Marcoulis, Chin Fen Teo, Julia Malato, Paul J. Phojanakong, Thomas G. Martin, Jeffrey L. Wolf, Sandy W. Wong, Nina Shah, Byron Hann, Angela N. Brooks, Arun P. Wiita
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
The mechanisms of action of proteasome inhibitors (PI) in multiple myeloma (MM) treatment are not fully elucidated. Here, the authors use unbiased phosphoproteomics in PI-treated MM and show increased phosphorylation of splicing-associated proteins,
Externí odkaz:
https://doaj.org/article/9ede6677994c4ad081bb8e902cda0b7a
Autor:
Sandy W. Wong, Nina Shah, Guy Ledergor, Thomas Martin, Jeffrey Wolf, Amy M. Shui, Chiung-Yu Huang, Joaquin Martinez-Lopez
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chimeric antigen receptor T-cell (CAR-T) therapy targeted against B-cell maturation antigen (BCMA) in multiple myeloma (MM) has produced rapid responses but many eventually relapse. In light of this new treatment, novel predictors of progression-free
Externí odkaz:
https://doaj.org/article/a957ad73193d4e8fa09a9df15122f49c
Autor:
Xun Ma, Sandy W. Wong, Ping Zhou, Chakra P. Chaulagain, Parul Doshi, Andreas K. Klein, Kellie Sprague, Adin Kugelmass, Denis Toskic, Melissa Warner, Kenneth B. Miller, Lisa Lee, Cindy Varga, Raymond L. Comenzo
Publikováno v:
Experimental Hematology & Oncology, Vol 7, Iss 1, Pp 1-10 (2018)
Abstract Background The monoclonal antibody daratumumab, approved for treating myeloma, targets CD38, a protein on myeloma and also on CD34+ hematopoietic progenitor cells. Because mobilized CD34+ cells are critical for stem cell transplant, we inves
Externí odkaz:
https://doaj.org/article/364a62290fbf4b409d7bc9bdc5e061ec
Autor:
Christine Lam, Ian D. Ferguson, Margarette C. Mariano, Yu-Hsiu T. Lin, Megan Murnane, Hui Liu, Geoffrey A. Smith, Sandy W. Wong, Jack Taunton, Jun O. Liu, Constantine S. Mitsiades, Byron C. Hann, Blake T. Aftab, Arun P. Wiita
Publikováno v:
Haematologica, Vol 103, Iss 7 (2018)
The myeloma bone marrow microenvironment promotes proliferation of malignant plasma cells and resistance to therapy. Activation of JAK/STAT signaling is thought to be a central component of these microenvironment-induced phenotypes. In a prior drug r
Externí odkaz:
https://doaj.org/article/0de808fc838c456d8a047ff83151b7c6
Autor:
Kevin R. Reyes, Chiung-Yu Huang, Mimi Lo, Shagun Arora, Alfred Chung, Sandy W. Wong, Jeffrey Wolf, Rebecca L. Olin, Thomas Martin, Nina Shah, Rahul Banerjee
Publikováno v:
Transplantation and Cellular Therapy. 29:350-355
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40c49a16ff58c3c7d25815f1726e3e48
https://doi.org/10.1016/j.jtct.2023.03.012
https://doi.org/10.1016/j.jtct.2023.03.012